Last reviewed · How we verify
NCT06873685: START-RUN1
Soft Tissue Sarcoma: Motor Performance, Robotic Rehabilitation, Nutrition, and Quality of Life
NA trial testing Rehabilitation in Sarcoma, Soft Tissue in 120 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Fondazione Policlinico Universitario Campus Bio-Medico |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 13 March 2025 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 August 2026 |
| Sites | 3 locations across Italy |
Drugs / interventions tested
- Rehabilitation
Conditions studied
- Sarcoma, Soft Tissue — all drugs for Sarcoma, Soft Tissue →
Sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Who can join
18 and older, any sex, with Sarcoma, Soft Tissue. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Soft tissue sarcomas are a group of rare and heterogeneous tumors. Surgery is the mainstay of treatment and microscopic negative margins need to be achieved to improve disease local control. We designed this prospective study to evaluate the main features of motor impairment and the impact of tailored robotic rehabilitation techniques in patients treated for localized soft tissue sarcoma (surgery alone, or surgery + radiation or radiochemotherapy). Specific patients' motor strategies will be quantitatively measured through a biomechanical assessment, including the analysis of joint kinematics, and muscle activity timing patterns. Considering the influence of motor impairment after demolitive surgery, a major interest of this study will be focused on nutrition and Quality of life which will be prospectively evaluated by specific questionnaires at different time points.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06873685
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Rehabilitation
Trials testing the same drug.
- NCT07320222 — CARE-Melanoma Trial · Phase 1 · not yet recruiting
- NCT06926699 — MPFL Reconstruction Versus Rehabilitation · NA · not yet recruiting
- NCT06818201 — Effects of tDCS on Motor Cortex During ACL Recovery · NA · recruiting
- NCT07105657 — The Outcome of Three Weeks Rehabilitation in Patients With a Total Hip or Knee Replacement Experiencing Persistent Physi · recruiting
- NCT06939309 — Efficacy of Acupuncture for Shoulder Pain Based on Remote Point Selection According to the Meridians · NA · not yet recruiting
Other recruiting trials for Sarcoma, Soft Tissue
Currently open trials in the same condition.
- NCT07071727 — Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas · NA · recruiting
Other Fondazione Policlinico Universitario Campus Bio-Medico trials
Trials by the same sponsor.
- NCT07119437 — Low Impact Laparoscopy In Bariatric Surgery · NA · recruiting
- NCT07029126 — Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symp · recruiting
- NCT06539000 — Preoperative Risk Score for Postoperative Right Ventricular Dysfunction in Adult Cardiac Surgery · completed
- NCT06974474 — Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study. · Phase 4 · recruiting
- NCT06537700 — OnaBotulinumtoxin-A in Chronic Migraine Patients With Short or Long Disease History (the BACH Study) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06873685 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondazione Policlinico Universitario Campus Bio-Medico
- Last refreshed: 21 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06873685.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing